Rubrik: Aktuelle Epidemiologie und Diagnostik in der Mikrobiologie
Eine Mykoplasmen-Welle schwappt über Deutschland und Europa (S. 14)
1. Chaudhry R, Ghosh A, Chandolia A. Pathogenesis of Mycoplasma pneumoniae: An update. Indian J Med Microbiol 2016; 34 (1): 7-16. doi: 10.4103/0255-0857.174112.
2. Taylor-Robinson D. Infections due to species of Mycoplasma and Ureaplasma: an update. Clin Infect Dis 1996; 23 (4): 671-682. doi: 10.1093/clinids/23.4.671.
3. Uphoff CC, Drexler HG. Eradication of Mycoplasma contaminations from cell cultures. Curr Protoc Mol Biol 2014; 106: 28.5.1-28.5.12. doi: 10.1002/0471142727.mb2805s106.
4. Qiu Y, Mao S, Li X, Chen Y, Chen W, Wen Y, Liu P. Chinese advances in understanding and managing genitourinary tract infections caused by Mycoplasma genitalium, Mycoplasma hominis, and Ureaplasma urealyticum. Arch Microbiol 2024; 207 (1): 5. doi: 10.1007/s00203-024-04204-z.
5. Beeton ML, Zhang XS, Uldum SA, Bébéar C, Dumke R, Gullsby K, Ieven M, Loens K, Nir-Paz R, Pereyre S, Spiller OB, Chalker VJ; ESCMID Study Group for Mycoplasma and Chlamydia Infections (ESGMAC) Mycoplasma pneumoniae subgroup; ESCMID Study Group for Mycoplasma and Chlamydia Infections (ESGMAC) Mycoplasma pneumoniae subgroup members not listed as an individual author. Mycoplasma pneumoniae infections, 11 countries in Europe and Israel, 2011 to 2016. Euro Surveill 2020; 25 (2): 1900112. doi: 10.2807/1560-7917.ES.2020.25.2.1900112.
6. Suttorp N, Welte T, Marre R, Stenger S, Pletz M, Rupp J, Schütte H, Rohde G; CAPNETZ-Studiengruppe. CAPNETZ. The competence network for community-acquired pneumonia (CAP). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2016; 59 (4): 475-481. German. doi: 10.1007/s00103-016-2318-7.
7. Dumke R, Schnee C, Pletz MW, Rupp J, Jacobs E, Sachse K, Rohde G; Capnetz Study Group. Mycoplasma pneumoniae and Chlamydia spp. infection in community-acquired pneumonia, Germany, 2011-2012. Emerg Infect Dis 2015; 21 (3): 426-434. doi: 10.3201/eid2103.140927.
8. Wetzke M, Schütz K, Kopp MV, Seidenberg J, Vogelberg C, Ankermann T, Happle C, Voigt G, Köster H, Illig T, Lex C, Schuster A, Maier R, Panning M, Barten G, Rohde G, Welte T, Hansen G. Pathogen spectra in hospitalised and nonhospitalised children with community-acquired pneumonia. ERJ Open Res 2023; 9 (2): 00286-2022. doi: 10.1183/23120541.00286-2022.
9. Daxboeck F, Krause R, Wenisch C. Laboratory diagnosis of Mycoplasma pneumoniae infection. Clin Microbiol Infect 2003; 9 (4): 263-73. doi: 10.1046/j.1469-0691.2003.00590.x.
10. Li W, Liu Y, Zhao Y, Tao R, Li Y, Shang S. Rapid diagnosis of Mycoplasma pneumoniae in children with pneumonia by an immuno-chromatographic antigen assay. Sci Rep 2015; 5: 15539. doi: 10.1038/srep15539.
11. Meyer Sauteur PM, Unger WWJ, van Rossum AMC, Berger C. The art and science of diagnosing Mycoplasma pneumoniae infection. Pediatr Infect Dis J 2018; 37 (11): 1192-1195. doi: 10.1097/INF.0000000000002171.
12. Gao L, Sun Y. Laboratory diagnosis and treatment of Mycoplasma pneumoniae infection in children: a review. Ann Med 2024; 56 (1): 2386636. doi: 10.1080/07853890.2024.2386636.
13. Gesellschaft für Pädiatrische Pneumologie (GPP) und der Deutschen Gesellschaft für Pädiatrische Infektiologie (DGPI). Management der ambulant erworbenen Pneumonie bei Kindern und Jugendlichen (paediatric community-acquired pneumonia, pCAP). AWMF-2Sk-Leitlinie Registernummer 048-013 (Stand 01/2024; Gültigkeit bis 01/2029).
14. Meyer Sauteur PM, Seiler M, Trück J, Unger WWJ, Paioni P, Relly C, Staubli G, Haas T, Gysin C, M Bachmann L, van Rossum AMC, Berger C. Diagnosis of Mycoplasma pneumoniae pneumonia with measurement of specific antibody-secreting cells. Am J Respir Crit Care Med 2019; 200 (8): 1066-1069. doi: 10.1164/rccm.201904-0860LE.
15. Meyer Sauteur PM, Trück J, van Rossum AMC, Berger C. Circulating antibody-secreting cell response during Mycoplasma pneumoniae childhood pneumonia. J Infect Dis 2020; 222 (1): 136-147. doi: 10.1093/infdis/jiaa062.
16. Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin (DGP), Paul-Ehrlich-Gesellschaft für Chemotherapie (PEG), Deutsche Gesellschaft für Infektiologie (DGI), Deutsche Gesellschaft für Internistische Intensivmedizin und Notfallmedizin (DGIIN), Gesellschaft für Virologie (GfV), Kompetenznetzwerk CAPNETZ, Deutsche Gesellschaft für Allgemeinmedizin (DEGAM), Deutsche Gesellschaft für Geriatrie (DGG), Deutsche Gesellschaft für Palliativmedizin (DGP), Österreichische Gesellschaft für Pneumologie (ÖGP), Österreichische Gesellschaft für Infektionskrankheiten und Tropenmedizin (ÖGIT), Schweizerische Gesellschaft für Pneumologie (SGP), und Schweizerische Gesellschaft für Infektiologie (SGInf). Behandlung von erwachsenen Patienten mit ambulant erworbener Pneumonie – Update 2021. AWMF-S3-Leilinie Registernummer 020-020 (Stand 04/2021; Gültigkeit bis 04/2025).
17. Ramaloko WT, Maningi NE, Osei Sekyere J. Global prevalence, resistance rates, and underlying resistance mechanisms of clinical Mycoplasma and Ureaplasma species. J Appl Microbiol 2025; 136 (1): lxae308. doi: 10.1093/jambio/lxae308.
18. European Centre for Disease Prevention and Control (ECDC). Increase in respiratory infections due to Mycoplasma pneumoniae in the EU/EEA during the season 2023/204. Communicable Disease Threats Report. Week 48. 2. Dezember 2023. https://www.ecdc.europa.eu/sites/default/files/documents/communicable-disease-threats-report-week-48-2023_0.pdf.
19. UK Health Security Agency. Mycoplasma pneumoniae surveillance in England and Wales, January 2019 to March 2024. https://www.gov.uk/government/publications/mycoplasma-pneumoniae-surveillance-january-2019-to-march-2024/mycoplasma-pneumoniae-surveillance-in-england-and-wales-january-2019-to-march-2024.
20. Bolluyt DC, Euser SM, Souverein D, van Rossum AM, Kalpoe J, van Westreenen M, Goeijenbier M, Snijders D, Eggink D, Jongenotter F, van Lelyveld SF, van Houten MA. Increased incidence of Mycoplasma pneumoniae infections and hospital admissions in the Netherlands, November to December 2023. Euro Surveill 2024; 29 (4): 2300724. doi: 10.2807/1560-7917.ES.2024.29.4.2300724.
21. Nordholm AC, Søborg B, Jokelainen P, Lauenborg Møller K, Flink Sørensen L, Grove Krause T, Anker Uldum S, Emborg HD. Mycoplasma pneumoniae epidemic in Denmark, October to December, 2023. Euro Surveill 2024; 29 (2): 2300707. doi: 10.2807/1560-7917.ES.2024.29.2.2300707.
22. Raghuram A, Furmanek S, Chandler T, Rashid S, Mattingly W, Ramirez J. Description of a Current Outbreak of Mycoplasma pneumoniae in the United States. Pathogens 2025; 14 (1): 60. doi: 10.3390/pathogens14010060.
23. Landesuntersuchungsanstalt für das Gesundheits- und Veterinärwesen (LUA). Jahresberichte für Infektionskrankheiten im Freistaat Sachsen. https://www.lua.sachsen.de/lua-jahresberichte-4103.html.
24. Dumke R. The high-incidence period of Mycoplasma pneumoniae infections 2023/2024 in southeast Germany was associated with a low level of macrolide resistance. Infection 2024; 52 (6): 2525-2527. doi: 10.1007/s15010-024-02336-4.
25. Meyer Sauteur PM, Beeton ML, Uldum SA, Bossuyt N, Vermeulen M, Loens K, Pereyre S, Bébéar C, Keše D, Day J, Afshar B, Chalker VJ, Greub G, Nir-Paz R, Dumke R; ESGMAC–MyCOVID Study Team. Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021. Euro Surveill 2022; 27 (19): 2100746. doi: 10.2807/1560-7917.ES.2022.27.19.2100746.
26. Meyer Sauteur PM, Beeton ML; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycoplasma and Chlamydia Infections (ESGMAC), and the ESGMAC Mycoplasma pneumoniae Surveillance (MAPS) study group. Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions. Lancet Microbe 2024; 5 (2): e100-e101. doi: 10.1016/S2666-5247(23)00344-0.
27. Guo Y, Yang D, Cao Y, Ding X, Chen L, Huo B, Li Y. Influence of COVID-19 public health restrictions on community-acquired pneumonia pathogens in children in Henan, China: a multicenter retrospective study. BMC Infect Dis 2024; 24 (1): 1381. doi: 10.1186/s12879-024-10268-5.
28. Liu P, Xu M, Lu L, Zhu X, Jia R, Dong N, Su L, Xu J. Resurgence of common respiratory viruses and mycoplasma pneumoniae after ending the zero-COVID policy in Shanghai. Sci Rep 2025; 15 (1): 1765. doi: 10.1038/s41598-025-85852-z.
